Tan, Carlyn Rose http://orcid.org/0000-0001-7922-2594
Shah, Urvi A.
Funding for this research was provided by:
Memorial Sloan Kettering NIH/NCI Cancer Center Support Grant (P30 CA008748)
Parker Institute for Cancer Immunotherapy
Article History
Accepted: 4 May 2021
First Online: 25 August 2021
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Carlyn Rose Tan has financial interests in Janssen as a result of an immediate family member’s employment. Urvi A. Shah has received research funding from Celgene/Bristol Myers Squibb, Janssen, and Parker Institute for Cancer Immunotherapy to her institution and honorariums for continuing medical education activity from the Physicians Education Resource, all outside of the submitted work.